JOB POSTING: The pediatric hematology-oncology division of the Centre Mère-Enfant-Soleil CHU de Québec, Laval University Pediatric Department, seeks a pediatric hematologist-oncologist for a full-time clinical position.

English text follows

Le service d’hémato-oncologie pédiatrique du Centre Mère-Enfant-Soleil du CHU de Québec, Département de pédiatrie de l’Université Laval, recherche un clinicien ou clinicien-chercheur spécialisé en hématologie-oncologie pédiatrique pour un poste à temps plein (PREM).

La personne recrutée se joindra à une équipe de 4 hémato-oncologues pédiatriques dont une œuvrant principalement en neuro-oncologie. L’équipe comprend aussi quatre pédiatres dédiés qui participent à la prise en charge hospitalisée de la clientèle oncologique, dont deux spécialisées en soins palliatifs, et deux radio-oncologues pédiatriques.

La pratique clinique en est une d’hémato-oncologie pédiatrique générale : oncologie pédiatrique (environ 80 nouveaux cas/année), hématologie générale, laboratoire (principalement interprétation frottis sanguin et médullaire ainsi que cytométrie en flux), recherche clinique (consortium COG, DFCI, Histiocyte Society, C17) et enseignement. Le développement d’un pôle de recherche fondamental au sein du service est un objectif à court-moyen terme. Dépendant des qualifications et de l’expérience du candidat, la proportion de pratique clinique versus autres sphères (recherche, implication  académique, gestion) sera à préciser.

Le service d’hémato-oncologie pédiatrique du Centre Mère-Enfant-Soleil du CHU de Québec a connu une forte croissance dans les dernières années, passant d’une moyenne de 50 cas/année en 2010 à environ 80 cas/année dans les dernières années. Le Centre Mère-Enfant-Soleil dessert un territoire d’environ deux millions d’habitants. De plus, comme notre service fait partie aussi d’un hôpital d’adulte (CHU de Québec), nous avons la possibilité de prendre en charge la clientèle « AYA » jusqu’au début de la vingtaine.

Par ailleurs, nous aurons la chance d’inaugurer à l’automne 2018 un nouveau pavillon Charles-Bruneau où se concentreront alors tous les soins de la clientèle hémato-oncologique pédiatrique du Centre Mère-Enfant Soleil.

La Ville de Québec est une ville de taille moyenne comprenant un centre-ville historique pittoresque, une gastronomie et une vie culturelle en essor ainsi qu’une proximité de la nature facilitant l’accès rapide à de nombreuses activités sportives (par exemple, centres de ski alpin à moins de 30 minutes de la ville). La qualité de vie y est ainsi maximisée et le rapport salaire-coût de la vie est très favorable.

Toute candidature sera étudiée mais les candidats canadiens seront priorisés. Les personnes intéressées doivent par ailleurs :

– détenir un diplôme de docteur en médecine

– détenir un certificat de spécialiste en hématologie-oncologie pédiatrique

– maîtriser la langue française

Avoir été formé pour participer au volet laboratoire sera un atout à la candidature ainsi qu’avoir quelques années d’expérience de pratique clinique.

Les personnes intéressées peuvent soumettre leur curriculum vitae ainsi qu’une lettre d’intérêt à :  Docteur Bruno Michon, bruno.michon at mail.chudequebec.ca


The pediatric hematology-oncology division of the Centre Mère-Enfant-Soleil CHU de Québec, Laval University Pediatric Department, seeks a pediatric hematologist-oncologist for a full-time clinical position.

The recruted member will join a team of 4 pediatric hematologist-oncologists, one of whom in charge of neuro-oncology. There are also four pediatricians that participate actively in clinical care of the inpatient oncology ward, two of whom are specialised in palliative care, as well as two pediatric radio-oncologists.

The clinical practice is one of general pediatric hematology-oncology: approximately 80 new oncology cases/year, general hematology, laboratory (mainly blood and marrow smear examination and flow cytometry) as well as clinical research (COG, DFCI, Histiocyte Society, C17) and teaching. Development of a fundamental or translational research focus is a short term goal.  Depending on the candidate’s expertise and experience, the proportion of clinical care versus other aspects (research, academics, administration) is to be determined.

The pediatric hematology-oncology division of the Centre Mère-Enfant-Soleil CHU de Québec has underwent a strong and constant growth over the last decade, evolving from about 50 oncology cases/year in 2010 to 80 cases/year over the past years. Our hospital covers a large population of approximately 2 million people. As our service is also in an adult hospital (CHU de Québec), we have the possibility of treating the « AYA » population, until their early twenties.

2018 will be an exciting year as we will be inaugurating a new hematology-oncology ward (pavillon Charles-Bruneau).

Quebec City is a medium size city with a beautiful historic downtown and a vibrant cultural and culinary scene. It is also in close proximity to a wide variety of outdoor activites (for example, alpine skiing centers are less than 30 minutes away). Quality of life is maximised and the salary to cost-of-living ratio is very favorable.

All candidates will be examined but priority will be given to Canadians. Interested candidates must:

– have a medical doctorate

– have a pediatric hematology-oncology specialist certificate

– have a good knowledge of French

Training in laboratory will also be a valued attribute as well as having a few years of clinical experience.

All interested individuals can submit their curriculum vitae and a letter of interest to:

Dr Bruno Michon, bruno.michon at mail.chudequebec.ca

Advertisements

JOB POSTING: The Hematology/Oncology Division at CHU Sainte-Justine is recruiting a clinician, clinician-investigator or clinician scientist specialized in hematology for a position of Assistant or Associate Professor

English text follows.

 

Le service d’Hématologie-Oncologie Pédiatrique du Centre Hospitalier Universitaire Sainte-Justine, Département de Pédiatrie de  l’Université de  Montréal, recherche un clinicien ou clinicien-chercheur spécialiste en hématologie pour un poste de Professeur Assistant ou Agrégé de clinique, afin de prendre en charge des patients avec maladies graves du sang, tels qu’anémie falciforme, cytopénies diverses, et   syndromes d’aplasie congénitale. La personne recrutée aura pour charge de participer activement aux taches cliniques de ce secteur, ainsi qu’aux diverses recherches cliniques et d’enseignement. Ces taches sont    intégrées par ailleurs à l’ensemble du service d’hématologie-oncologie. Une collaboration très étroite est particulièrement attendue avec les autres médecins du service experts en hématologie.

 

Les personnes intéressées doivent

  • détenir un diplôme de docteur en médecine,
  • détenir un certificat de spécialiste en hématologie ou hématologie-oncologie,
  • avoir complété, au moment de leur intégration, une formation complémentaire dans les domaines d’expertise recherchés
  • faire preuve de leadership
  • et avoir un fort esprit d’équipe.

 

Une formation spécialisée en hématologie-oncologie pédiatrique n’est pas requise, mais sera considéré comme un atout important. De même, une formation complémentaire en anémie falciforme sera considérée comme un atout important.

La maîtrise de la langue française est nécessaire aux activités cliniques et de gestion.

Les candidatures seront étudiées attentivement, même si le candidat n’est pas disponible dans les prochains mois. Les candidatures ayant besoin d’une formation complémentaire seront également étudiées attentivement.

Les personnes intéressées peuvent prendre contact avec l’un des co-chefs de  service d’hématologie-oncologie du CHU Sainte-Justine :

Yves Pastore Yves.pastore@umontreal.ca

Ou Michel Duval Michel.duval@umontreal.ca

 

CHU Sainte-Justine

Service d’hématologie et centre de cancérologie Charles-Bruneau 3175 Côte Sainte-Catherine

Montréal (QC) H3T1C5

Tel : 514 v345 4931, poste 4870

Ou 514-345-4639

 

Le CHU Sainte-Justine est un hôpital universitaire mère-enfant de 500 lits, assurant les soins tertiaires et quaternaires pour l’ensemble de la Province du Québec (7.8 millions d’habitants). L’agrandissement important du centre de cancérologie Charles- Bruneau et la désignation comme un des axes de développement prioritaire pour le CHU s’accompagne d’une nouvelle ambition pour le service d’Hématologie-Oncologie. Le service compte 14 hématologues-oncologues pédiatriques, et vise à court terme à engager 3 médecins supplémentaires. La section d’hématologie est en plein essors, suivant une cohorte d’anémie falciforme en constante expansion, atteignant à ce jour plus de 350 patients suivis, une large cohorte de patients avec cytopénies diverses, dont plus d’une trentaine de patients avec syndrome d’aplasie congénitale, plus de 250 patients avec troubles congénitaux de l’hémostase sont , et plus de 150 patients sont actifs dans le programme de thrombose et anticoagulation, une clinique d’hémostase au féminin. Le programme d’aphérèse réalise plus de 250 procédures par année. Le service intègre de plus des laboratoires de diagnostic de pointe en hématologie-cytologie, hémostase et thrombose. Le laboratoire de thérapie cellulaire soutient le programme clinique de greffe, et la banque de sang assure l’ensemble des transfusions du CHU. Plus de 140 nouveaux patients atteints de leucémie ou cancer sont pris en charge chaque année. Le centre de jour reçoit plus de 15,000 visites par année, et l’unité d’hospitalisation dispose de 32 lits. Le programme de transplantation hématopoïétique (50 transplantations par année) est accrédité FACT et dispose d’une unité de 12 lits. Le service conduit une intense activité de recherche fondamentale, translationnelle et clinique, notamment en hématologie.

Au cœur d’une très active métropole multiculturelle de 3.7 millions d’habitants, le CHU Sainte-Justine et son Centre de Recherche sont situés à proximité immédiate du campus universitaire de l’Université de Montréal. Le Centre de Recherche compte plus de 200 chercheurs, dont plus de 90 chercheurs-cliniciens, et plus de 450 étudiants de cycles supérieurs et post-doctorants, réunis dans un nouveau bâtiment de neuf étages. Cet environnement de recherche profite de la richesse du milieu académique montréalais et de la collaboration de groupe de recherche de la Province de Québec.

Le programme d’enseignement de l’hématologie-oncologie pédiatrique est agréé par le Collège Royal des Médecins du Canada. Ce programme de formation est reconnu internationalement, comme en témoigne la présence permanente de quatre moniteurs cliniques (fellows) venant de l’extérieur du Québec.


The CHU Sainte-Justine Pediatric Hematology-Oncology Division, Department of Pediatrics, Université de Montréal, is seeking to recruit a clinician, clinician-investigator or clinician scientist specialized in hematology for a position of Assistant or Associate Professor, to take care of patients with blood diseases as sickle cell disease, cytopenias and congenital aplasia.

The recruit will participate to all clinical care activities in Hemato-Oncology in children and pregnant women. Clinical, research and teaching and management activity will be particularly oriented toward hematology. Very close collaboration is expected will the other physicians of the division specialized in hematology.

Interested applicants, including clinician-investigators and clinician-scientists, must

  • hold an MD
  • hold a certificate of specialist in hematology or hematology-oncology
  • have completed a full complementary training in the field of expertise at the time of their recruitment
  • have strong leadership capability
  • and a good team spirit

 

A specialization in pediatric hematology-oncology is not required but will be considered a strong asset. Training in sickle cell disease will also be considered as a strong asset.

Working knowledge of French language is needed for the clinical and administrative activities.

All applications will be studied thoroughly, even if the applicant is not available in the coming months. Applicants needing to begin a complementary training will also be seriously considered.

Please contact one of the Division co-chairs : Yves Pastore

Yves.pastore@umontreal.ca

Or Michel Duval Michel.duval@umontreal.ca

 

CHU Sainte-Justine

Hematology service and Charles Bruneau Cancer Center 3175 Côte Sainte-Catherine

Montréal (QC) H3T1C5

Tel : 514 v345 4931, poste 4870

Or 514-345-4639

Or 514-345-4639

CONSIDER CIRCULATING: Ewings Cancer Foundation of Canada (ECFC) has produced a documentary for wide distribution to educate non-oncology physicians, coaches, teachers and others on the importance of early detection of Ewing sarcoma and the impact of misdiagnosis.

*Approx 47 minutes. May not be suitable for young viewers.

Ewing sarcoma is difficult to identify and often gets misdiagnosed allowing the cancer to proliferate beyond treatable stages.  If you read the personal stories on the ECFC website, there is recurring theme of misdiagnosis (e.g., sport or dance injury). Early detection is critical to avoiding metastasis, which is associated with a drop from 50-70% survival rate to an unacceptable 10-15% survival rate.

ECFC has produced this 47 minute documentary for wide distribution to help educate on realities of Ewing sarcoma.   Find below a letter of introduction from ECFC.


Dear Doctors,

What do you know about Ewing sarcoma? Most know very little and, shockingly, this can also be true about health professionals. It is a nondiscriminatory, aggressive cancer that primarily attacks the bones and soft tissue in younger people but can affect anyone at any age. Characteristically one of the most painful forms of cancer, tragically Ewing sarcoma is difficult to identify and often gets misdiagnosed allowing the cancer to proliferate beyond treatable stages. Currently, Ewing sarcoma is being treated successfully in 50-70% of cases identified using dated chemo regimes that are more than 35 years old. As you know, once it starts to spread, survival rates plummet to just 10-15%. We know old chemo regimes are damaging young, growing bodies and endangering the survivors with their lifelong health complications. This, in turn, becomes a burden on an already stretched healthcare system. There is no measure on the physical, emotional and financial tole of their families.

 

 

The Ewings Cancer Foundation of Canada (ECFC) is a registered charity who has spent the last 10 years fighting tirelessly to raise awareness and ultimately for the eradication of Ewing sarcoma (ES) through fundraising efforts sponsoring critical research and development initiatives in Canada. The ECFC was formed by Tina Pernica and her husband Bernie in 2008 after the death of their 19 year old son, Reid. Tina and Reid spent many hours combing the internet, in vain, for information on ES to make sense of what was happening to him before he passed away. To their surprise, there was very little out there and more surprising was the lack of knowledge amongst the healthcare community. This was unacceptable to them and Reid vowed that should he survive, he would make a difference in Canada, increasing awareness and research in Ewing sarcoma. After his death, his parents carried on his pledge and today the ECFC has funded 4 critical research grants through a partnership with C17 Council, the Children’s Cancer and Blood Disorders group in Alberta, with a 5th coming soon

 

 

Over the past 10 years, the ECFC have learned from patients this cancer is most often overlooked as it mimics growing pains, sports injuries or an inflammatory condition, delaying diagnosis with devastating consequences. We knew we had to do something about increasing awareness within the medical community. In 2017, the Ewings Cancer Foundation of Canada produced Make It Stop, the first and only professional feature length documentary (47 minutes) about Ewing sarcoma in the world to date. Shot and produced in Canada, it is the very first educational tool created for front line health care practitioners who may or may not be familiar with ES, including chiropractors, sports and massage therapists, radiology and the rheumatology communities to name a few. Featured in this film are Drs. Adam Shlien, David Malkin and Abha Gupta at SickKids, Toronto; Dr. Jason Berman in Dalhousie University, Halifax; and Dr. Poul Sorensen at the BC Cancer Care Centre, Vancouver.

 

Please view this film here: https://www.youtube.com/watch?v=WYavC9GZpeg. We invite your comments and feedback once you do! We know that knowledge is power and with that power we can help stop this devastating cancer from taking the health and lives from society’s most vulnerable, the young. We ask you to include this documentary in your newsletters, industry publications, medical workshops, conferences, lectures, and/or symposiums and educational events for all registered rheumatologists across Canada.
Early detection is vital and can make the difference between life and death.

 

 

It is our hope we can work together to increase awareness for Ewing sarcoma especially within the Rheumatology Sector.

 

 

With sincere appreciation,

 

 

 

Tina Pernica
President & Founder
Ewings Cancer Foundation of Canada
Charitable Registration # 83833 0025 RR0001

O: 905-737-0127

JOB POSTING: locum Pediatric Hematologist-Oncologist at BC Children’s Hospital. Applications accepted until filled.

Pediatric Hematologist-Oncologist

Competition # HEML-T1.0-13
Locum Full Time Position (May – December 2018)
Division of Pediatric Hematology, Oncology, and Bone Marrow Transplantation
Department of Pediatrics
University of British Columbia
BC Children’s Hospital
Vancouver, BC Canada

The Department of Pediatrics, Division of Hematology, Oncology, Bone and Marrow Transplantation has an outstanding opportunity for a locum Pediatric Hematologist-Oncologist to join our well established team at BCCH.

Responsibilities encompass patient care, teaching. Applicants must have passed or be eligible for the Royal College of Physicians and Surgeons of Canada examinations in pediatrics, and will have completed a recognized training program in pediatric hematology/oncology. Additional training and/or an established track record in clinical oncology and hematology is preferred as well as additional expertise in neuro oncology.

The successful candidate will be appointed at the appropriate Clinical Faculty rank at the University of British Columbia, Faculty of Medicine. Academic rank and clinical salary will be based on qualifications and experience.

The anticipated start date is May 2018.

Applications will be accepted until the position has been filled. Interested individuals should quote competition # HEML-T1.0-13 submit their most current CV, cover letter and names of three references as soon as possible to:

Caron Strahlendorf, MB.BCh., FCP, FRCPC
Head, Division of Pediatric Hematology/Oncology/BMT
BC Children’s Hospital
e-mail: cstrahlendorf at cw.bc.ca

For more information on all that the PHSA has to offer, please visit jobs.phsa.ca.

For more information about the BC Children’s Hospital, please visit bcchildrens.ca.

BCCH and the UBC Department of Pediatrics hire on the basis of merit and encourage all qualified persons.


BC Children’s Hospital (BCCH) cares for the most acutely ill or injured children and youth. BCCH also provides developmental and rehabilitation services to children and youth throughout BC, and operates a wide number of specialized health programs provided through a number of health services provider groups. As the main pediatrics clinical training site for the Faculty of Medicine at the University of British Columbia (UBC), BCCH is the leading acute care teaching facility in the province, and conducts research to advance health and knowledge through the BC Children’s Research Institute, and collaborations with other institutions.

BCCH is an agency of the Provincial Health Services Authority (PHSA) which plans, manages and evaluates specialty and province-wide health care services across BC. PHSA embodies values that reflect a commitment to excellence. These include:

Respect people • Be compassionate • Dare to innovate • Cultivate partnerships • Serve with purpose

The Oncology/Hematology/BMT program has relocated to the new Teck Acute Care Centre (TACC). The new inpatient unit features 27 single-patient rooms. The new outpatient unit features 23 single-patient rooms. The program sees 140 new oncology patients and 400 new hematology consultations per year, and performs 25 transplants annually. Additionally, the program is a funded member of the Children’s Oncology Group and has a highly productive research program with over 3 million dollars of grant funding per year.

Ensure the pediatric view is contributed to the review of the ” Canadian Cancer Statistics publication” – contribute to this 5 minute survey before the end of Feb 15

This message was originally circulated as an email sent on behalf of Dr Leah Smith, Chair, 2018 Canadian Cancer Statistics Advisory Committee.

The Canadian Cancer Statistics Advisory Committee is in the process of conducting a review of the Canadian Cancer Statistics publication. This may mean changes to the publication’s content, format and frequency. We need your input to help make sure our decisions support the needs of the cancer community.

How can you help? Please complete this questionnaire. It should not take more than 15 minutes. [Note: actually less than 5 if you don’t have additional information to add to the comment boxes.]

Who should complete this questionnaire? This questionnaire is for anyone who uses cancer statistics. Even if you are not familiar with the Canadian Cancer Statistics publication, your input is important.

The questionnaire will be available between January 24 and February 15 in English [link] and French [link]

The more responses we receive, the better equipped we’ll be to make sure the Canadian Cancer Statistics publication meets the needs of its stakeholders. If you know of someone whose input would be valuable, please forward them this email.

Thank you in advance for helping make sure this resource is as valuable as possible to you, your colleagues and Canadians who depend on cancer statistics.

 

CHEO is seeking locum physicians to cover several leaves in their peds hem/onc division

CHEO is seeking locum physicians to cover several leaves in our Division. There are openings Immediately and for the upcoming 18 months.   Weekend, week long, or longer term all available. Please contact Donna Johnston (djohnston at cheo.on.ca) if you have any availability or forward to other with potential availability.

CYP-C Research Champion Webinars: An Introduction to CYP-C Institutional Reports – AKA – How to access your own data!

Topic: An Introduction to CYP-C Institutional Reports – AKA – How to access your own data!

Date: Friday, February 23, 2018
Time: 12:00 pm, Eastern Standard Time
For webinar information, contact Randy Barber in the C17 Office (randy.barber@AHS.ca)


Research Champion Webinars (2018)

The objective of this webinar series is to provide members of the Canadian pediatric cancer community a broad understanding of how to access and utilize the Cancer in Young People in Canada data for research purposes. This series will include an overview of how to (1) develop an appropriate research question, (2) complete the data access process and (3) perform basic data manipulation and analysis using SAS and Microsoft Access. The webinars will be delivered once per month over the 2018 calendar year. We look forward to your participation!

Past webinars are available on the C17 website under committees>CYP-C

CONFIRMED (2018; times are noon EST unless stated)
Institutional Reports (Feb 23)

FORTHCOMING (2018)
Flat File Reports
Data Manipulation in Access

PAST

Past webinars are available on the C17 website under committees>CYP-C
1. pdf-icon.gif Developing a Research Question – L Sung

2. pdf-icon.gif Overview and Requesting Data – S Badour, E Martineau, R Barber
video.JPG 

3. pdf-icon.gif Power Literature Searching – E Uleryk    video.JPG 
pdf-icon.gif Power Search PubMed [reference materials]

4. pdf-icon.gif Using SAS to analyze CYP-C data: An introduction – J Pole    video.JPG 

5. pdf-icon.gif Using SAS to analyze CYP-C data: Advanced – J Pole    video.JPG 

6. pdf-icon.gif Grant Writing Tips and Tricks – L Rosella    video.JPG 

7. pdf-icon.gif SAS Procedures – J Pole    video.JPG 

8. pdf-icon.gif Data Cleaning – G Giuseppe   video.JPG 

9. pdf-icon.gif GIS for CYP-C Research – C Nielsen  video.JPG 
excel.png Test Data [reference materials]

10. pdf-icon.gif SIOP2017 Census Geography – J Pole  video.JPG  

11. pdf-icon.gif Data Analysis I – J Pole  video.JPG 

12. pdf-icon.gif Data Analysis II – J Pole  video.JPG 

CRS Scholarships for the Next Generation of Scientists: 2018 Competition

The Cancer Research Society is pleased to announce the launch of its 2018 Scholarships for the Next Generation of Scientists competition, an initiative aiming at supporting future generations of Canadian researchers. The Scholarship is broken down into two parts, and extends over a period of 3 years, with no possibility for renewal.

Deadlines for submitting an application: April 27, 2018, 11:59 pm (EST).

Part 1: Postdoctoral Salary Award – 1 year * – $40,000 :  One year postdoctoral salary award for a candidate finishing his/her fellowship. The candidate must have completed at least two years of postdoctoral training at the time he/she accepts the salary award.

* Possibility of extending Part 1 of this award for a maximum period of 6 months.

Part 2: Operating Grant – 2 years – $120,000 ($60,000/year) :  Operating grant award once the candidate has obtained a faculty position at a recognized Canadian institution.

You have two options for submitting your application.

  1. Using the WeTransfer file transfer service. The deadline for submitting your electronic files via WeTransfer is April 27, 2018, 11:59 pm (EST).
  2. Saving on two (2) CDs or two (2) USB keys and sending it by mail or courier, as per the instructions on our website. The deadline for mailing your application is April 27, 2018. Applications must be postmarked on or before this date.

For additional information on the competition, please visit our website.

For all questions, please contact Lucille Beaudet or Irina Navarrete at grants@src-crs.ca or, toll free, 1 888-766-2262.

Thank you!
Lucille Beaudet
Ph.D., MBA


La Société de recherche sur le cancer est heureuse d’annoncer le lancement de son concours 2018 de Bourses pour la relève scientifique. Ce programme vise à appuyer financièrement la future génération de chercheurs canadiens. Il comporte deux volets, et couvre une période de 3 ans sans possibilité de renouvellement.

Date limite pour soumettre une demande : 27 avril 2018, 23 h 59 (HNE).

Volet 1 : Bourse salariale pour stage postdoctoral – 1 an* – 40 000 $ :  Bourse salariale d’une année pour un candidat en fin de stage postdoctoral. Le candidat devra avoir complété deux ans de sa formation postdoctorale lorsqu’il acceptera la bourse salariale.
* Possibilité d’une extension d’un maximum de 6 mois.

Volet 2 : Subvention de fonctionnement – 2 ans – 120 000 $ (60 000 $ / an) :  Subvention de fonctionnement versée au candidat qui aura obtenu un poste de chercheur dans une institution canadienne reconnue.

Nous vous offrons deux méthodes pour la soumission de votre demande :

  1. Vous pouvez soumettre les fichiers électroniques de votre demande en utilisant l’application de transfert de fichier WeTransfer. La date limite pour effectuer le transfert de vos fichiers avec WeTransfer est le 27 avril 2018, 23 h 59 (HNE).
  2. Vous pouvez également envoyer votre demande sauvegardée sur deux CDs ou deux clés USB par la poste ou par service de messagerie (date limite d’envoi : le 27 avril 2018, le sceau de la poste en faisant foi).

Pour plus d’information sur le programme de Bourses pour la relève scientifique, veuillez consulter notre site Web.

Pour toutes questions, communiquez avec Lucille Beaudet ou Irina Navarrete à subventions@src-crs.ca ou, sans frais, au 1 866-343-2262.

Merci !

Lucille Beaudet
Ph.D., MBA

JOB POSTING: FT Academic Physician at McMaster Peds Hem/Onc

The full posting can be downloaded here: 1.0 GFT Posting_HematologyOncology.Jan2018

The Department of Pediatrics at McMaster University and McMaster Children’s Hospital are seeking a full-time academic physician to join the Division of Pediatric Hematology-Oncology. The successful candidate will join a Division with twelve members (including two radiation oncologists and a research scientist). The successful candidate will be expected to have a graduate degree in clinical epidemiology and an interest in Global Health and marginalized populations. The successful candidate’s responsibilities will include further development of the After Care component of the program, sharing in the delivery of the comprehensive clinical services offered by the division and participating in research and educational activities.

McMaster University is internationally recognized for innovations in medical education and pioneering biomedical, epidemiological and health systems research. Located in Hamilton, on the edge of Lake Ontario and the picturesque Niagara escarpment, McMaster Children’s Hospital is a tertiary referral center serving a population of more than 2.3 million. The Division of Pediatric Hematology-Oncology is a member of the Children’s Oncology Group. The Division is a research-intensive group; the successful candidate will be encouraged to develop a clinical investigative agenda as well as participate in educational activities within the Royal College accredited pediatric and pediatric hematology-oncology training programs.

The position will incorporate an academic appointment appropriate to the qualifications and expertise of the applicant. We offer a collegial atmosphere, a unique academic environment, many research opportunities and the opportunity to work in a growing academic department with enthusiastic colleagues.

PEDS LIVER GRANT: call for proposals from the Canadian Liver Foundation includes a grant targeted to pediatric liver disease research in Ontario

Dear Researchers,
The Canadian Liver Foundation (CLF) is pleased to announce a call for proposals for the following:

  • 4 Operating Grants
  • 3 Summer Studentships

Operating Grants

  • Two operating grants may be awarded to researchers in Canada whose research projects are related to hepatobiliary research.
  • One operating grant may be awarded to a researcher in Ontario whose research project is related to liver cancer.
  • One operating grant may be awarded to a researcher in Ontario whose research project is related to pediatric liver disease.

Summer Studentships

Three Raj Bhargava Memorial Summer Studentships may be awarded for research projects related to radiology of liver disease at the University of Alberta.


For details, please refer to the respective grant application guidelines http://www.liver.ca/professionals/researchers/#grant-competition

To apply, download the appropriate grant application form www.liver.ca/professionals/researchers/#grant-competition

The deadline for submission of applications is March 31, 2018.